| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2018 | 59.20 | 59.20 | 56.00 | 58.00 | 33,170 |
| Oct 12, 2018 | 54.00 | 59.00 | 54.00 | 58.00 | 27,197 |
| Oct 11, 2018 | 54.85 | 55.00 | 52.00 | 56.00 | 14,183 |
| Oct 10, 2018 | 62.10 | 63.50 | 56.10 | 56.00 | 47,649 |
| Oct 9, 2018 | 62.30 | 62.90 | 62.10 | 65.00 | 3,836 |
| Name | ReNeuron Group | Epic | RENE |
|---|---|---|---|
| ISIN | GB00BF5G6K95 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 1,000 | Prev Close | 58.00 |
| Shares in Issue (m) | 31.65 | Market Cap (£m) | 18.36 |
| PE Ratio | -1.04 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -55.70 | EPS Growth (%) | -11,040.00 |
| PEG | 0.00 | DPS Growth (%) | n/a |
| ROCE | -57.19 | Net Gearing | -51.53 |
| Quick Ratio | 7.01 | Current Ratio | 7.01 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 09 Nov | Stifel | Buy | 58.00 | 13.00 | 13.00 | Reiterates |
| 29 Jun | N+1 Singer | Buy | 58.00 | - | - | Reiterates |
| 27 Apr | N+1 Singer | Buy | 58.00 | 9.00 | 9.00 | Reiterates |
| 04 Apr | Stifel | Buy | 58.00 | 15.00 | 15.00 | Reiterates |
| 04 Jan | N+1 Singer | Buy | 58.00 | 9.00 | 9.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 27 Sep 2018 | Olav Hellebo | Buy | 14,936 @ 66.90p | £9,992.18 |
| 27 Sep 2018 | Michael Hunt | Buy | 7,462 @ 67.00p | £4,999.54 |
| 07 Feb 2017 | Michael Hunt | Buy | 250,000 @ 2.64p | £6,600.00 |
| 17 Feb 2016 | Michael Hunt | Exercise | 5,361,673 @ 1.00p | £53,616.73 |
| 17 Feb 2016 | Michael Hunt | Sale Post-Exercise | 5,111,673 @ 2.86p | £146,193.85 |
